Eli Lilly and Co (LLY)

LLY (NYSE:Drugs) EQUITY
$79.20
pos +2.80
+3.70%
Today's Range: 76.02 - 78.40 | LLY Avg Daily Volume: 4,139,200
Last Update: 05/29/15 - 10:11 AM EDT
Volume: 1,346,854
YTD Performance: 10.76%
Open: $76.15
Previous Close: $76.41
52 Week Range: $58.50 - $77.46
Oustanding Shares: 1,109,741,140
Market Cap: 83,119,611,386
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 5 5
Moderate Buy 1 1 1 1
Hold 5 6 9 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.95 2.04 2.23 2.23
Latest Dividend: 0.50
Latest Dividend Yield: 2.67%
Dividend Ex-Date: 05/14/15
Price Earnings Ratio: 36.54
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
36.54 36.60 26.97
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
8.89% 27.99% 85.87%
GROWTH 12 Mo 3 Yr CAGR
Revenue -15.10 -0.19 -0.07
Net Income -49.00 -0.45 -0.18
EPS -48.50 -0.43 -0.17
Earnings for LLY:
EBITDA 4.71B
Revenue 19.62B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $0.74 $0.77 $3.15 $3.52
Number of Analysts 7 7 11 10
High Estimate $0.80 $0.85 $3.21 $3.91
Low Estimate $0.68 $0.68 $3.09 $3.21
Prior Year $0.68 $0.66 $2.78 $3.15
Growth Rate (Year over Year) 9.24% 16.88% 13.41% 11.65%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Update
May 04, 2015 | 6:35 AM EDT
LLY - Eli Lilly and Co Annual Shareholders Meeting - 11AM
Combined Heinz-Kraft heads a long second-quarter list.
Its Alzheimer's treatment impressed, but dosing questions remain.
Lilly's stock blossoms, while Amgen is headed for a pullback.
Here are healthcare stocks of all shares and sizes with strong charts.
Update
Feb 11, 2015 | 6:41 AM EST
Leerink Global Healthcare Conference (Day 1 of 2) - 02/11/15 - 02/12/15 New York, NY

Prep for Dividend D-Day Danger Real Money Pro($)

Should you be tempted by the energy names?
Bullish
Jan 15, 2015 | 7:08 AM EST
LLY was upgraded to Neutral, Goldman Sachs said. $70 price target. Company is improving margins and can deliver double-digit annual ear...
Bearish
Jan 09, 2015 | 7:08 AM EST
LLY was downgraded to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $74 price target. 
Bearish
Jan 08, 2015 | 8:01 AM EST
LLY was downgraded from Buy to Hold, Deutsche Bank said. $75 price target. Valuation call, as the stock gained 35% in 2014. 

Columnist Conversations

I had written up Xilinx (XLNX) this past January when the shares dipped under $38. Intel's deal for industry...
I totally agree with you on the business cycle and non-intervention here. The repeated interventions have crea...
I continue to expect the yield on the 10 year US note to gravitate back down towards 2.00% this Summer. By ye...
1Q2015 GDP was revised to a contraction of -0.7% vs the initial print of up +0.2%. The estimate was for a decl...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.